Sfoglia per AUTORE
LEE HC
Collezione AOU Città della Salute di Torino
Items : 2
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US. in Annals of hematology / Ann Hematol. 2021 Sep;100(9):2325-2337. doi: 10.1007/s00277-021-04534-8. Epub 2021 May 10.
2021
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Zonder J; Boccadoro M; Thompson M; Weisel K; Berdeja J; Lee HC; Leleu X; Huang H; Stull DM; Cherepanov D; Terpos E; Hajek R; Romanus D; Palumbo A; Abonour R; Usmani S; Morgan G; Costello C; Rifkin R; Davies F; Cook G; Puig N; Vela-Ojeda J; Farrelly E; Raju A; Blazer M; Chari A;
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. in Blood cancer journal / Blood Cancer J. 2021 Feb 18;11(2):40. doi: 10.1038/s41408-021-00432-4.
2021
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Terpos E; Mikhael J; Hajek R; Chari A; Zweegman S; Lee HC; Mateos MV; Larocca A; Ramasamy K; Kaiser M; Cook G; Weisel KC; Costello CL; Elliott J; Palumbo A; Usmani SZ;